Vulvar carcinoma: The price of less radical surgery

The objective of this study was to determine whether modifications in the treatment of patients with vulvar carcinoma influence the rates of recurrence and survival. Between 1982 and 1997, 253 patients with T1 and T2 invasive squamous cell carcinoma of the vulva were treated by essentially the same...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer 2002-12, Vol.95 (11), p.2331-2338
Hauptverfasser: DE HULLU, Joanne A, HOLLEMA, Harry, LOLKEMA, Sietske, BOEZEN, Marike, BOONSTRA, Henk, BURGER, Matthe P. M, AALDERS, Jan G, MOURITS, Marian J. E, VAN DER ZEE, Ate G. J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2338
container_issue 11
container_start_page 2331
container_title Cancer
container_volume 95
creator DE HULLU, Joanne A
HOLLEMA, Harry
LOLKEMA, Sietske
BOEZEN, Marike
BOONSTRA, Henk
BURGER, Matthe P. M
AALDERS, Jan G
MOURITS, Marian J. E
VAN DER ZEE, Ate G. J
description The objective of this study was to determine whether modifications in the treatment of patients with vulvar carcinoma influence the rates of recurrence and survival. Between 1982 and 1997, 253 patients with T1 and T2 invasive squamous cell carcinoma of the vulva were treated by essentially the same team of gynecologic oncologists, and 168 patients (Group I) underwent radical vulvectomy with en bloc inguinofemoral lymphadenectomy. Standard therapy was changed in 1993, and 85 patients (Group II) underwent wide local excision with inguinofemoral lymphadenectomy through separate incisions. The rates of recurrence and survival were compared between both groups. In Group II, the overall recurrence rate (33.3%) within 4 years was increased compared with Group I (19.9%; P = 0.03). In Group II, 5 of 79 patients (6.3%) developed fatal groin or skin bridge recurrences compared with 2 of 159 patients (1.3%) in Group I (P = 0.029); this did not result in a difference in overall survival. In Group II, 40 of 79 patients had tumor free margins measuring 8 mm, resulting in no local recurrences (P = 0.002). The current study showed that fatal recurrences in either the groin or the skin bridge were more frequent after wide local excision and inguinofemoral lymphadenectomy through separate incisions; however, probably due to lack of power, this did not result in shorter survival. In 40 of 79 patients, the histologic margins measured
doi_str_mv 10.1002/cncr.10969
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72686263</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72686263</sourcerecordid><originalsourceid>FETCH-LOGICAL-c272t-7e2b356cc7bd2cd6d2b0980509c9dcf55a10def6f0b5f80d593dcfc315af94753</originalsourceid><addsrcrecordid>eNpFkMtKAzEUhoMotlY3PoDMRhfC6EkyyUzcSfEGBTdV3A2Zk0RH5lKTjtC3N7UDXZ0LHz_nfIScU7ihAOwWO_SxU1IdkGmseQo0Y4dkCgBFKjL-MSEnIXzHMWeCH5MJZRmXGVdTwt-H5lf7BLXHuutbfZcsv2yy8jXapHdJY0NIvDY16iYJg_-0fnNKjpxugj0b64y8PT4s58_p4vXpZX6_SJHlbJ3mllVcSMS8MgyNNKwCVYAAhcqgE0JTMNZJB5VwBRiheFwjp0I7leWCz8jVLnfl-5_BhnXZ1gFt0-jO9kMocyYLySSP4PUORN-H4K0r4_2t9puSQrlVVG4Vlf-KInwxpg5Va80eHZ1E4HIEdIhfO687rMOey4Arxij_AxmYbi8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72686263</pqid></control><display><type>article</type><title>Vulvar carcinoma: The price of less radical surgery</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><source>Alma/SFX Local Collection</source><creator>DE HULLU, Joanne A ; HOLLEMA, Harry ; LOLKEMA, Sietske ; BOEZEN, Marike ; BOONSTRA, Henk ; BURGER, Matthe P. M ; AALDERS, Jan G ; MOURITS, Marian J. E ; VAN DER ZEE, Ate G. J</creator><creatorcontrib>DE HULLU, Joanne A ; HOLLEMA, Harry ; LOLKEMA, Sietske ; BOEZEN, Marike ; BOONSTRA, Henk ; BURGER, Matthe P. M ; AALDERS, Jan G ; MOURITS, Marian J. E ; VAN DER ZEE, Ate G. J</creatorcontrib><description>The objective of this study was to determine whether modifications in the treatment of patients with vulvar carcinoma influence the rates of recurrence and survival. Between 1982 and 1997, 253 patients with T1 and T2 invasive squamous cell carcinoma of the vulva were treated by essentially the same team of gynecologic oncologists, and 168 patients (Group I) underwent radical vulvectomy with en bloc inguinofemoral lymphadenectomy. Standard therapy was changed in 1993, and 85 patients (Group II) underwent wide local excision with inguinofemoral lymphadenectomy through separate incisions. The rates of recurrence and survival were compared between both groups. In Group II, the overall recurrence rate (33.3%) within 4 years was increased compared with Group I (19.9%; P = 0.03). In Group II, 5 of 79 patients (6.3%) developed fatal groin or skin bridge recurrences compared with 2 of 159 patients (1.3%) in Group I (P = 0.029); this did not result in a difference in overall survival. In Group II, 40 of 79 patients had tumor free margins measuring &lt;or= 8 mm, resulting in 9 local recurrences; whereas 39 of 79 patients had tumor free margins measuring &gt; 8 mm, resulting in no local recurrences (P = 0.002). The current study showed that fatal recurrences in either the groin or the skin bridge were more frequent after wide local excision and inguinofemoral lymphadenectomy through separate incisions; however, probably due to lack of power, this did not result in shorter survival. In 40 of 79 patients, the histologic margins measured &lt;or= 8 mm, resulting in a high risk of local recurrences. Therefore, the authors recommend obtaining surgical margins of 2 cm for the local treatment of patients with vulvar carcinoma.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.10969</identifier><identifier>PMID: 12436439</identifier><identifier>CODEN: CANCAR</identifier><language>eng</language><publisher>New York, NY: Wiley-Liss</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Carcinoma - pathology ; Carcinoma - surgery ; Female ; Follow-Up Studies ; Humans ; Lymph Node Excision ; Medical sciences ; Middle Aged ; Mortality ; Neoplasm Recurrence, Local ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the genital tract and mammary gland ; Treatment Outcome ; Vulvar Neoplasms - pathology ; Vulvar Neoplasms - surgery</subject><ispartof>Cancer, 2002-12, Vol.95 (11), p.2331-2338</ispartof><rights>2003 INIST-CNRS</rights><rights>Copyright 2002 American Cancer Society.DOI 10.1002/cncr.10969</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c272t-7e2b356cc7bd2cd6d2b0980509c9dcf55a10def6f0b5f80d593dcfc315af94753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14039221$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12436439$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DE HULLU, Joanne A</creatorcontrib><creatorcontrib>HOLLEMA, Harry</creatorcontrib><creatorcontrib>LOLKEMA, Sietske</creatorcontrib><creatorcontrib>BOEZEN, Marike</creatorcontrib><creatorcontrib>BOONSTRA, Henk</creatorcontrib><creatorcontrib>BURGER, Matthe P. M</creatorcontrib><creatorcontrib>AALDERS, Jan G</creatorcontrib><creatorcontrib>MOURITS, Marian J. E</creatorcontrib><creatorcontrib>VAN DER ZEE, Ate G. J</creatorcontrib><title>Vulvar carcinoma: The price of less radical surgery</title><title>Cancer</title><addtitle>Cancer</addtitle><description>The objective of this study was to determine whether modifications in the treatment of patients with vulvar carcinoma influence the rates of recurrence and survival. Between 1982 and 1997, 253 patients with T1 and T2 invasive squamous cell carcinoma of the vulva were treated by essentially the same team of gynecologic oncologists, and 168 patients (Group I) underwent radical vulvectomy with en bloc inguinofemoral lymphadenectomy. Standard therapy was changed in 1993, and 85 patients (Group II) underwent wide local excision with inguinofemoral lymphadenectomy through separate incisions. The rates of recurrence and survival were compared between both groups. In Group II, the overall recurrence rate (33.3%) within 4 years was increased compared with Group I (19.9%; P = 0.03). In Group II, 5 of 79 patients (6.3%) developed fatal groin or skin bridge recurrences compared with 2 of 159 patients (1.3%) in Group I (P = 0.029); this did not result in a difference in overall survival. In Group II, 40 of 79 patients had tumor free margins measuring &lt;or= 8 mm, resulting in 9 local recurrences; whereas 39 of 79 patients had tumor free margins measuring &gt; 8 mm, resulting in no local recurrences (P = 0.002). The current study showed that fatal recurrences in either the groin or the skin bridge were more frequent after wide local excision and inguinofemoral lymphadenectomy through separate incisions; however, probably due to lack of power, this did not result in shorter survival. In 40 of 79 patients, the histologic margins measured &lt;or= 8 mm, resulting in a high risk of local recurrences. Therefore, the authors recommend obtaining surgical margins of 2 cm for the local treatment of patients with vulvar carcinoma.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Carcinoma - pathology</subject><subject>Carcinoma - surgery</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Lymph Node Excision</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Neoplasm Recurrence, Local</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the genital tract and mammary gland</subject><subject>Treatment Outcome</subject><subject>Vulvar Neoplasms - pathology</subject><subject>Vulvar Neoplasms - surgery</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkMtKAzEUhoMotlY3PoDMRhfC6EkyyUzcSfEGBTdV3A2Zk0RH5lKTjtC3N7UDXZ0LHz_nfIScU7ihAOwWO_SxU1IdkGmseQo0Y4dkCgBFKjL-MSEnIXzHMWeCH5MJZRmXGVdTwt-H5lf7BLXHuutbfZcsv2yy8jXapHdJY0NIvDY16iYJg_-0fnNKjpxugj0b64y8PT4s58_p4vXpZX6_SJHlbJ3mllVcSMS8MgyNNKwCVYAAhcqgE0JTMNZJB5VwBRiheFwjp0I7leWCz8jVLnfl-5_BhnXZ1gFt0-jO9kMocyYLySSP4PUORN-H4K0r4_2t9puSQrlVVG4Vlf-KInwxpg5Va80eHZ1E4HIEdIhfO687rMOey4Arxij_AxmYbi8</recordid><startdate>20021201</startdate><enddate>20021201</enddate><creator>DE HULLU, Joanne A</creator><creator>HOLLEMA, Harry</creator><creator>LOLKEMA, Sietske</creator><creator>BOEZEN, Marike</creator><creator>BOONSTRA, Henk</creator><creator>BURGER, Matthe P. M</creator><creator>AALDERS, Jan G</creator><creator>MOURITS, Marian J. E</creator><creator>VAN DER ZEE, Ate G. J</creator><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20021201</creationdate><title>Vulvar carcinoma: The price of less radical surgery</title><author>DE HULLU, Joanne A ; HOLLEMA, Harry ; LOLKEMA, Sietske ; BOEZEN, Marike ; BOONSTRA, Henk ; BURGER, Matthe P. M ; AALDERS, Jan G ; MOURITS, Marian J. E ; VAN DER ZEE, Ate G. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c272t-7e2b356cc7bd2cd6d2b0980509c9dcf55a10def6f0b5f80d593dcfc315af94753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Carcinoma - pathology</topic><topic>Carcinoma - surgery</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Lymph Node Excision</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Neoplasm Recurrence, Local</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the genital tract and mammary gland</topic><topic>Treatment Outcome</topic><topic>Vulvar Neoplasms - pathology</topic><topic>Vulvar Neoplasms - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DE HULLU, Joanne A</creatorcontrib><creatorcontrib>HOLLEMA, Harry</creatorcontrib><creatorcontrib>LOLKEMA, Sietske</creatorcontrib><creatorcontrib>BOEZEN, Marike</creatorcontrib><creatorcontrib>BOONSTRA, Henk</creatorcontrib><creatorcontrib>BURGER, Matthe P. M</creatorcontrib><creatorcontrib>AALDERS, Jan G</creatorcontrib><creatorcontrib>MOURITS, Marian J. E</creatorcontrib><creatorcontrib>VAN DER ZEE, Ate G. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DE HULLU, Joanne A</au><au>HOLLEMA, Harry</au><au>LOLKEMA, Sietske</au><au>BOEZEN, Marike</au><au>BOONSTRA, Henk</au><au>BURGER, Matthe P. M</au><au>AALDERS, Jan G</au><au>MOURITS, Marian J. E</au><au>VAN DER ZEE, Ate G. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vulvar carcinoma: The price of less radical surgery</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>2002-12-01</date><risdate>2002</risdate><volume>95</volume><issue>11</issue><spage>2331</spage><epage>2338</epage><pages>2331-2338</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><coden>CANCAR</coden><abstract>The objective of this study was to determine whether modifications in the treatment of patients with vulvar carcinoma influence the rates of recurrence and survival. Between 1982 and 1997, 253 patients with T1 and T2 invasive squamous cell carcinoma of the vulva were treated by essentially the same team of gynecologic oncologists, and 168 patients (Group I) underwent radical vulvectomy with en bloc inguinofemoral lymphadenectomy. Standard therapy was changed in 1993, and 85 patients (Group II) underwent wide local excision with inguinofemoral lymphadenectomy through separate incisions. The rates of recurrence and survival were compared between both groups. In Group II, the overall recurrence rate (33.3%) within 4 years was increased compared with Group I (19.9%; P = 0.03). In Group II, 5 of 79 patients (6.3%) developed fatal groin or skin bridge recurrences compared with 2 of 159 patients (1.3%) in Group I (P = 0.029); this did not result in a difference in overall survival. In Group II, 40 of 79 patients had tumor free margins measuring &lt;or= 8 mm, resulting in 9 local recurrences; whereas 39 of 79 patients had tumor free margins measuring &gt; 8 mm, resulting in no local recurrences (P = 0.002). The current study showed that fatal recurrences in either the groin or the skin bridge were more frequent after wide local excision and inguinofemoral lymphadenectomy through separate incisions; however, probably due to lack of power, this did not result in shorter survival. In 40 of 79 patients, the histologic margins measured &lt;or= 8 mm, resulting in a high risk of local recurrences. Therefore, the authors recommend obtaining surgical margins of 2 cm for the local treatment of patients with vulvar carcinoma.</abstract><cop>New York, NY</cop><pub>Wiley-Liss</pub><pmid>12436439</pmid><doi>10.1002/cncr.10969</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-543X
ispartof Cancer, 2002-12, Vol.95 (11), p.2331-2338
issn 0008-543X
1097-0142
language eng
recordid cdi_proquest_miscellaneous_72686263
source MEDLINE; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection); Alma/SFX Local Collection
subjects Adult
Aged
Aged, 80 and over
Biological and medical sciences
Carcinoma - pathology
Carcinoma - surgery
Female
Follow-Up Studies
Humans
Lymph Node Excision
Medical sciences
Middle Aged
Mortality
Neoplasm Recurrence, Local
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the genital tract and mammary gland
Treatment Outcome
Vulvar Neoplasms - pathology
Vulvar Neoplasms - surgery
title Vulvar carcinoma: The price of less radical surgery
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T13%3A21%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vulvar%20carcinoma:%20The%20price%20of%20less%20radical%20surgery&rft.jtitle=Cancer&rft.au=DE%20HULLU,%20Joanne%20A&rft.date=2002-12-01&rft.volume=95&rft.issue=11&rft.spage=2331&rft.epage=2338&rft.pages=2331-2338&rft.issn=0008-543X&rft.eissn=1097-0142&rft.coden=CANCAR&rft_id=info:doi/10.1002/cncr.10969&rft_dat=%3Cproquest_cross%3E72686263%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72686263&rft_id=info:pmid/12436439&rfr_iscdi=true